Curis Begins Phase I Clinical Study With Vascugel in Coronary Artery Disease
Curis, Inc. (NASDAQ: CRIS) today announced the initiation of a Phase I clinical trial in the U.S. with Vascugel, a cellular transplant […]
You may also like
State of the Art Review: Surgical Treatment of Acute Type A Aortic Dissection
This review provides an overview of the current surgical treatment of ATAAD, focusing on new disease classifications, preoperative computed tomography angiography (CTA) assessment, new prosthesis and stent technologies, and organ-protection strategies.